Glucotrack (GCTK) Return on Sales (2014 - 2020)

Glucotrack's Return on Sales history runs 7 years deep, the most recent figure standing at 0.55% for Q3 2020.

• Quarterly Return on Sales rose 327.0% year-over-year to 0.55% in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.55% (up 134.0% YoY) and the FY2019 annual result came in at 0.31%, up 326.0% from the prior year.
• Return on Sales was 0.55% for Q3 2020 at Glucotrack, up from 63.75% in the prior quarter.
• Across five years, Return on Sales topped out at 0.95% in Q4 2019 and bottomed at 63.75% in Q2 2020.
• A 5-year average of 4.13% and a median of 0.14% in 2016 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2019 — Return on Sales jumped 370 bps — and 2020, when it plunged 6367 bps.
• Glucotrack's Return on Sales stood at 0.71% in 2016, then soared by 125 bps to 0.17% in 2017, then plunged by 1675 bps to 2.75% in 2018, then soared by 134 bps to 0.95% in 2019, then plunged by 42 bps to 0.55% in 2020.
• Business Quant data shows GCTK's Return on Sales at 0.55% in Q3 2020, 63.75% in Q2 2020, and 4.22% in Q1 2020.